INTRODUCTION
============

The early Brånemark protocol prescribed a healing period of 6 to 8 months between tooth extraction and implant placement \[[@B1]\]. It was believed that this was necessary to avoid infection and to allow for better primary stability at implant placement.

Continuing research lead to the introduction of immediate placement, where the implant is installed in conjunction with tooth extraction. The advantages of immediate placement are the reduced number of surgical interventions and the shortened overall treatment time \[[@B2]-[@B4]\]. Additionally, some researchers believe that immediate implant placement may improve the aesthetic outcome due to the reduced risk of bone resorption and the maintenance of gingival and crestal bone architecture \[[@B3],[@B5]\]. A 50% reduction in horizontal bone width occurs during the first year after tooth extraction. In the vertical dimension, a 2.4 to 4.5 mm decrease in bone height may occur. This bone resorption is especially pronounced in the molar region and when neighbouring teeth are absent \[[@B6]-[@B9]\]. In some cases, the reduction in bone volume is so extensive that it might prevent the delayed placement (16 weeks) of an implant \[[@B10],[@B11]\].

On the other hand, immediate placement has some disadvantages, such as the risk of infection, unpredictable soft and hard tissue response(s), the difficulty to achieve primary stability and the critical positioning of the implant \[[@B12],[@B13]\]. Especially in subjects with a thin biotype, immediate placement is not recommended due to the risk of recession over time \[[@B14]\]. In periodontally-susceptible patients, immediate implantation might also increase the risk of implant failure \[[@B15]\]. In contradiction to what was initially believed, does immediate placement not prevent the resorption of the buccal bone, which is part of the natural healing process after tooth extraction \[[@B16]-[@B18]\].

According to a review by Quirynen et al. \[[@B13]\] immediately placed implants demonstrate a mean failure rate of 6.2%, ranging from 0% to 40%. However, studies comparing the outcome between immediate and delayed placement, found no significant difference in survival rate \[[@B19]-[@B22]\].

Most studies deal with the replacement of a monoradicular tooth. Immediate implantation into a molar socket raises an extra challenge for the clinician, because of the difficulty in positioning the implant, due to the residual inter-radicular bone \[[@B23]\].

Placing a regular diameter implant in one of the existing root sockets will result in a compromised emergence profile, significant off-angle loading, and the creation of a cantilever effect \[[@B24]\]. A wide diameter implant will enhance bicortical primary stability, increase the surface for osseointegration \[[@B25],[@B26]\] and will result in a more axial, prosthetically oriented position.

Early publications on wide diameter implants reported more than 20% implant failures \[[@B26],[@B27]\], however more recent studies using surface modified implants report lower failure rates of less than 5% \[[@B28]-[@B31]\]. A moderately rough surface and adapted surgical protocol may promote the anchorage in the bone and decrease implant failures \[[@B32],[@B33]\].

To achieve primary stability in molar extraction sockets more easily, a new wide diameter, tapered implant was introduced. The aim of this study was to evaluate retrospectively the clinical outcome of this implant design when placed immediately into maxillary and mandibulary molar extraction sockets.

MATERIAL AND METHODS
====================

**Implant design**

The Max® implant (Southern Implants, Irene, South Africa) can be 7 to 10 mm wide and 7, 9 or 11 mm long. It has a tapered design with a 0.8 mm thread pitch ([Figure 1](#fig1){ref-type="fig"}). They have an external hex and a moderately rough surface created by sandblasting and chemically conditioned with solvents of a grade 4 c.p. titanium, with a Sa value of 1.34 \[[@B34],[@B35]\]. Due to the wide diameter, there is a platform switching of 0.25 mm in the horizontal plane and a further 0.35 mm when the 45 degree bevel is included.

![Representation of the Max® implant.](jomr-02-e1-g001){#fig1}

**Surgical procedure**

Following comprehensive clinical and radiographic examination of the patient and the associated molar tooth, all patients were supplied with formal written treatment plans. The indication for tooth extraction and immediate implant placement was extensive loss of coronal tooth material, preventing conventional prosthetic treatment. The immediate placement approach was only considered for patients with an intact buccal socket wall and a medium or thick periodontal biotype, since it has been shown that a thin biotype is more prone to recession and aesthetical complications and is therefore less suited for immediate placement \[[@B36]\]. Assessment of the biotype was based on the transparency of the periodontal probe as described by De Rouck et al. \[[@B37]\]. A signed consent was required from each patient prior to treatment.

On the day of surgery, local anaesthetic wasadministered, but no attempt was made to remove the tooth with conventional extraction forceps. As immediate implant placement is critically dependant on the preservation of the perimeter bony walls of the socket, the extractions were carried out by sectioning of the tooth to allow for removal of the roots individually and to avoid potential fracture of any of the associated bony elements, especially the buccal plate ([Figure 2](#fig2){ref-type="fig"}).

![Clinical case representing the surgical procedure:\
A = Caries and substantial loss of tooth material indicated extraction of first molar.\
B = The roots were split to allow atraumatic extraction.\
C = The intact septum was used as a reference to position the first round drill.\
D = Depending on the bone quality, the site was formed using a tapered drill, bone tap or osteotome.\
E = When the implant bed was prepared, the implant was ready to be installed.\
F = If the residual space exceeded 2 mm, a bone graft was used to fill the residual space.\
G = Baseline radiograph, taken immediately after surgery.\
H = A healing abutment was connected to the implant and the flap was closed.\
I = Radiograph taken 13 months after surgery showing stable bone level around the implant neck.\
J = Intraoral view of the final implant crown.](jomr-02-e1-g002){#fig2}

The crown of the molar was always cut off horizontally. The roots were then carefully separated and the inter-radicular bone within the socket was used to manipulate the roots, which were then elevated without removal of any bone. Piezo surgery was often utilized to assist with removal of the roots and if root removal proved to be challenging, 4.3 times magnification surgical loupes with fibre optic illumination were used to assist with the surgery. Once all the roots were removed successfully, the bony socket walls were inspected to confirm the presence of 4 intact outer walls and the absence of any pathology or fenestrations.

Preparation of the inter-radicular bonewas then initiated. A round bur waspositioned onto the inter-radicular septum. The point at which the drill was placed was always slightly off-centre towards the lingual in the case of a mandibular molar and often slightly towards the mesial in the case of an maxillary molar. This is to allow for preparation of the implant placement site in a centrally located position, but away from the buccal bone plate. Slight mesially positioned preparation in maxillary molar sockets was only performed, if the available interdental bone between the maxillary first molar and the maxillary second premolar was more than that available between the first and second molar. If this slight adjustment is overlooked, the implant could end up being placed too close to the maxillary second molar.

Preparation was then followed by a 1.2 mm, 2.00 mm, 2.85 mm and 3.07 mm diameter twist drill. This was followed by a 4, 5 and 6 mm diameter tapered spade drills of the correct length. Specially designed tapered wide diameter drills were then used next, especially in the case of mandibular molars where denser bone was encountered. In the case of a maxillary molar, further preparation of the site was often carried out from this point onwards with dedicated surgical taps. These allow for slow and careful preparation of the bone and enables lateral compaction of the prepared bone as opposed to further bone removal which is commonly anticipated with drilling. This was especially useful in the maxillary molar sockets, where bone quality is usually Type III-IV. To clarify in more detail, three potential preparation methods were employed after the 6 mm tapered spade drill. These were carried out using one or a combination of the following:

1\) Custom designed osteotomes whichcorrespond to the size of the available implants: 7, 8, 9 mm diameter and 7, 9, or 11 mm in length. Osteotomes wereusually used in a very soft bone, where no drilling is required. They were often useful in second molar sockets with little or no inter-radicular bony anatomy.

2\) Custom designed 7, 8, or 9 mm diameter tapered drills with lengths of 7, 9, or 11 mm. Usually used in hard bone and when there is a very prominent inter-radicular bony anatomy present.

3\) Custom designed surgical taps, which correspond to the size of the available implants: 7, 8, 9 mm diameter and 7, 9, or 11 mm in length. Usually used in soft bone and when there is little need to remove more bone with further drilling. Also, used when the greater site preparation control was needed as the taps allow for slow and careful preparation.

Once preparation was complete, one of the custom designed osteotomes was used to place in the osteotomy site and act as a profile gauge. A peri-apical radiograph would then be taken to verify the position and depth of the osteotomy preparation.To compensate for natural bone resorption after tooth extraction, the implant site must allow the implant to be seated 2 mm below the margin of the intact buccal bony wall and is therefore prepared 2 mm deeper, compared to delayed implantation \[[@B16]\].

After site preparation, the implant is installed at low speed using the implant surgical unit. In all cases, the implant was primarily seated at 50 Ncm with the implant surgical unit and then finally seated by hand with an implant insertion wrench until the implant platform ended 2 mm subcrestally. The implant must also be positioned well away from the buccal bony wall of the socket, to avoid damage and recession \[[@B36]\]. Ideally, one would like to see the remaining buccal strut of the inter-radicular bony septum still intact and butting up against the implant.If theresidual socket space was more than 2 mm wide, a bone graft was used, e.g. a bovine derived xenograft (Bio-Oss^®^, Geistlich, Wolhusen, Switzerland; Nu-Oss^®^, Ace Surgical Supply, Brockton, MA, USA) or irradiated allogenic cancellous bone (ICB^®^, Rocky Mountain Tissue Bank, Aurora, CO, USA) \[[@B38],[@B39]\].

A healing abutment was then connected and tightened. Soft tissue adaptation around the healing abutment was assisted with Vicryl 4.0 sutures and a post-operative peri-apical radiograph was taken with a parallel-aiming device. All patients received a course of antibiotics (2 x Amoxicillin 500 mg / day for 7 days) and analgesics (3 x Ibuprofen 800 mg / day for 3 days, 2 x paracetamol 500 mg / day for 1 day) as well as Corsodyl mouthwash (GlaxoSmithKline Consumer Healthcare, Brentford, Middlesex, UK) after implant surgery. All the cases were followed-up with a postoperative evaluation within 10 - 14 days after surgery.

**Patient selection**

All patients, consecutively treated by one experienced periodontist (AH) with one or multiple Max^®^ implants, were personally invited by phone to attend a clinical research examination. Only implants placed in molar extraction sockets with at least 1 year follow-up post-surgery were included.

Patients, who chose not to attend the examination were asked if the implant was still in function and whether they had experienced any problems with the implant or prosthetic restoration. This method has been described before and was done to detect possible failures or complications \[[@B40]\].

This study was approved by the Ethical Comité of the University Hospital Ghent, Belgium and is in accordance with the Helsinki Declaration.

**Clinical examination**

Implant data were collected from patient files and clinical examination. Surgical parameters were time of loading, 1 or 2 stage surgery, type of bone graft, implant position and implant dimensions.

Patient related parameters were smoking and gender.

The implant prosthetics were categorized into 3 groups: single crowns, fixed partial prosthesis and fixed full prosthesis. The type of prosthetic retention (cement-retained or screw-retained) was also recorded.

The papilla fill was measured according to the papilla index by Jemt \[[@B41]\]. If the neighbouring tooth, crown or pontic was absent, no value was recorded.

**Radiographic analyses**

During examination, digital peri-apical radiographs (Vista Scan, Dürr Dental AG, Bietigheim-Bissingen, Germany) were taken using the long-cone paralleling technique and to determine the peri-implant bone loss after comparison with a baseline radiograph taken immediately after surgery. An X-ray holder was used to orient the X-ray beam perpendicular with the implant axis. Radiographic analyses were done by the one independent examiner (SVDW) not involved in the initial implant treatment using DBSWIN software (Dürr Dental AG, Bietigheim-Bissingen, Germany) with an accuracy of 0.1 mm. Radiographs were calibrated using the known thread pitch as a reference. Bone level was determined from implant-abutment connection to the first bone-to-implant contact mesial and distal. The mean of both values was taken as the implant bone level. The actual bone loss or bone gain was calculated as the difference between baseline and follow-up.

Each individual implant was dichotomised as either a success (value 1) or a survival (value 0), using a mathematical formula to link bone loss and time. Implants up to one year in function were called \"implant bone loss success\", when bone loss during the first year was ≤ 1.5 mm; implants longer than one year in function were successful, when bone loss was ≤ 1.5 + (0.2 x \[Time in months - 12\]/12) mm, based on the internationally accepted criteria of Albrektsson and Isidor \[[@B42]\], allowing a maximum of 1.5 mm bone loss during the first year and 0.2 mm yearly thereafter.

**Statistical analysis**

Statistics were performed with PASW v18 for Windows (SPSS^®^, Chicago, Illinois, USA). Mann Whitney U-test and Kruskal-Wallis Test were used for bone loss analyses. Chi-Square was used for statistical comparison of implant failure and success rate. P \< 0.05 was considered statistically significant.

RESULTS
=======

In total, 98 implants installed in 89 patients answered to the selection criteria. All patients could be reached by telephone and confirmed that their implant was still present. Only 1 implant failed prior to loading, resulting in an overall 98.98% implant survival rate.

38 patients (12 male, 26 female) with 47 implants were available for clinical examination (Table 1). The mean age was 60 years (SD 11.64, range 25 - 83). Twenty six implants were placed in the maxilla and 21 in the mandible. A detailed overview of implant distribution according to implant position can be seen in [Figure 3](#fig3){ref-type="fig"}. Table 2 represents an overview of implant length according to implant diameter. In the maxilla, 69.2% of the implants were 9 mm in diameter, while in the mandible, 76.2% of the implants were 8 mm in diameter. This was significantly different (P = 0.002).

###### 

Table representing frequency distribution, bone loss and implant success for the different variables

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                             **Implants**\    **Bone loss**\                         **P-value**                            **Implant**\                   **P-value**     **Time**\      
                             **number**       **(mm)**                                                                      **success**                                    **(months)**   
  -------------------------- ---------------- -------------------------------------- -------------------------------------- ------------------------------ --------------- -------------- ------------------------------
  **Gender**                 Male             15                                     0.41 (SD 0.56, range 0.00 -- 1.95)     0.836                          14/15 (93.3%)   0.140          22 (SD 6.02; range 14 -- 32)

  Female                     32               0.38 (SD 0.45, range - 0.50 -- 1.55)   32/32 (100%)                           19 (SD 5.61; range 12 -- 35)                                  

                                                                                                                                                                                          

  **Jaw**                    Maxilla          26                                     0.48 (SD 0.52; range - 0.50 -- 1.95)   0.050^a^                       25/26 (96.2%)   0.364          21 (SD 6.01; range 12 -- 35)

  Mandible                   21               0.27 (SD 0.42; range - 0.05 -- 1.35)   21/21 (100%)                           20 (SD 5.66; range 12 -- 32)                                  

                                                                                                                                                                                          

  **Implant diameter**       8 mm             24                                     0.23 (SD 0.42; range - 0.50 -- 1.35)   0.008^b^                       24/24 (100%)    0.302          18 (SD 3.69; range 12 -- 26)

  9 mm                       23               0.55 (SD 0.50; range 0.00 -- 1.95)     22/23 (95.7%)                          22 (SD 6.76; range 13 -- 35)                                  

                                                                                                                                                                                          

  **Implant length**         7 mm             5                                      0.79 (SD 0.63; range 0.10 -- 1.55)     0.205                          5/5 (100%)      0.613          21 (SD 4.44; range 13 -- 24)

  9 mm                       18               0.28 (SD 0.36; range - 0.50 -- 0.80)   18/18 (100%)                           20 (SD 4.90; range 16 -- 32)                                  

  11 mm                      24               0.38 (SD 0.51; range 0.00 -- 1.95)     23/24 (95.8%)                          20 (SD 6.70; range 12 -- 35)                                  

                                                                                                                                                                                          

  **Smoking**                Yes              2                                      0.83 (SD 1.03, range 0.10 -- 1.55)     0.426                          2/2 (100%)      0.831          19 (SD 7.78; range 13 -- 24)

  No                         45               0.37 (SD 0.46, range - 0.50 -- 1.95)   44/45 (97.8%)                          20 (SD 5.81; range 12 -- 35)                                  

                                                                                                                                                                                          

  **Bone graft**             No               17                                     0.43 (SD 0.50; range - 0.15 -- 1.55)   0.480                          17/17 (100%)    0.395          19 (SD 3.77; range 13 -- 28)

  Bio-Oss                    12               0.53 (SD 0.59; range 0.00 -- 1.95)     11/12 (91.7%)                          25 (SD 7.75; range 14 -- 35)                                  

  ICB                        14               0.18 (SD 0.29; range - 0.50 -- 0.60)   14/14 (100%)                           19 (SD 4.48; range 12 -- 26)                                  

  Nu-Oss                     4                0.48 (SD 0.53; range 0.00 -- 1.20)     4/4 (100%)                             16 (SD 2.38; range 12 -- 17)                                  

                                                                                                                                                                                          

  **Prosthetic**\            Single crown     38                                     0.41 (SD 0.45; range 0.00 -- 1.95)     0.429                          37/38 (97.4%)   0.886          20 (SD 6.02; range 12 -- 35)
  **restoration**                                                                                                                                                                         

  Fixed partial prosthesis   6                0.27 (SD 0.73; range - 0.50 -- 1.55)   6/6 (100%)                             18 (SD 3.66; range 13 -- 24)                                  

  Fixed full prosthesis      3                0.47 (SD 0.42; range 0.00 -- 0.80)     3/3 (100%)                             23 (SD 6.93; range 19 -- 31)                                  

                                                                                                                                                                                          

  **Prosthetic**\            Screw-retained   45                                     0.40 (SD 0.48; range - 0.50 -- 1.95)   0.103                          44/45 (97.8%)   0.880          20 (SD 5.85; range 12 -- 35)
  **retention**                                                                                                                                                                           

  Cemented                   1                \- 0.15                                1/1 (100%)                             17                                                            
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^Statistically significant difference in bone loss between maxilla and mandible (Mann-Whitney U test, P \< 0.05).

^b^Statistically significant difference in bone loss between 8 and 9 mm diameter implants (Mann-Whitney U test, P \< 0.05).

###### 

Implant distribution according to implant diameter and length

                    **Diameter (mm)**   Total        
  ----------------- ------------------- ------- ---- ---
  **Length (mm)**   7                   2       3    5
  9                 11                  7       18   
  11                11                  13      24   
  Total             24                  23      47   

![Overview of implant distribution according to implant position.](jomr-02-e1-g003){#fig3}

No implant failures occurred in the examined patients. The mean peri-implant bone loss was 0.38 mm (SD 0.48; range - 0.50 - 1.95), after a mean follow-up period of 20 months (SD 5.75; range 12 - 35) ([Figure 4](#fig4){ref-type="fig"}). There were no significant changes in the bone loss between the different 6 months intervals (P = 0.487) ([Figure 5](#fig5){ref-type="fig"}). The overall individual implant success rate was 97.9% (46/47).

![Peri-apical radiographs representing the bone levels around the Max^®^ implant over time:\
A = Pre-operative radiograph. Due to its poor prognosis, the decision was made to extract the tooth.\
B = Baseline radiograph, taken on the day of surgery. The implant is placed slightly subcrestally.\
C = Radiograph taken after 3 months.\
D = Radiograph taken after 2 years of loading. The bone level is stable and situated at the implant neck.](jomr-02-e1-g004){#fig4}

![Box-plot representing the mean bone loss and range per 6 months\' time interval.](jomr-02-e1-g005){#fig5}

All implants were placed following a 1 stage approach and delayed loading. Univariate analysis showed significantly more bone loss in the maxilla (mean = 0.48 mm, SD 0.52, range - 0.50 - 1.95) compared to the mandible (mean = 0.27 mm, SD 0.42, range - 0.05 - 1.35) (P = 0.050). Furthermore, more bone loss was seen around the 9 mm diameter implants (mean = 0.55 mm, SD 0.50, range 0.00 - 1.95) compared to the 8 mm diameter implants (mean = 0.23 mm, SD 0.42, range - 0.50 - 1.35) (P = 0.008) (Table 1).

At the mesial side, the papilla filled the interproximal space completely at 76.1% of the sites, more than half at 19.6% and less than half at 4.3% of the sites. At the distal side, the papilla filled the interproximal space completely at 62.1%, more than half at 31% and less than half at 6.9% of the sites. There was no significant difference in bone loss between the different scores at the mesial side (P = 0.236) or distal side (P = 0.180), or in success rate at mesial (P = 0.852) or distal (P = 0.316) side.

DISCUSSION
==========

The 98.98% implant survival is in accordance with other studies on immediate placement reporting survival rates over 92% after at least 1 year follow-up \[[@B24],[@B43]-[@B53]\]. Although it was partially based on telephonic contact, Vercruyssen et al. \[[@B40]\] demonstrated the reliability of this technique. The survival rate also corresponds to the outcome of an earlier multicenter study using this implant design, reporting a 95.7% implant survival rate for the immediately placed Max^®^ implants \[[@B54]\]. However, some of the immediate implants in that study were submerged during healing or immediately loaded, which might explain the lower survival rate in that study and makes comparison not completely valid.

The population in a private practice may differ from the one in clinical research projects executed at academic centres. Although infection control measures were taken before surgery and oral hygiene was adequate, patients were not excluded from the study for certain risk factors as smoking or diabetes. Despite this, these data reflect reality and the outcome is comparable to highly-controlled studies.

Although some authors report more bone loss around wide diameter implants compared to regular diameter implant \[[@B55]\], the amount of bone loss was only 0.38 mm after at least 1 year follow-up. This is in accordance with other studies and far within the criteria for success \[[@B29]-[@B31],[@B56],[@B57]\]. Although one could argue that the clinical follow-up is too short, one has to keep in mind that a marked stability of the bone level during the first six months after surgery is normally an indication of a minimal risk for future implant failure or further bone loss unless periimplantitis or traumatic overloading are involved. This being said, it remains of course necessary that the studied implant and presented treatment protocol are scrutinized further after a longer follow-up time for further validation.

Today, very few studies reported on bone loss around implants immediately placed in molar sockets. Bianchi and Sanfilippo \[[@B58]\] reported a 0.75 mm bone loss after at least 72 months follow-up and Penarrocha et al. \[[@B19]\] reported 0.83 mm bone loss after 1 year. Prosper et al. \[[@B59]\] reported a bone level of 0.17 mm after 1 year and 1.01 after 5 years. These results indicate that immediate placement generates limited bone loss, which is stable over time.

Bone loss was significantly lower in the mandible compared to the maxilla, which is in accordance with earlier studies \[[@B20],[@B60]\]. Jawbone quality and quantity are more often compromised in maxillary than in mandibular sites and may therefore affect the implant treatment outcome \[[@B61]\].

Wide-diameter implants have reported an increased failure rate, mainly associated with the operators\' learning curves, poor bone density, implant design and site preparation, and its use when primary stability had not been achieved with a standard-diameter implant \[[@B33]\]. Innovations in surgical protocol and implant design made their outcome comparable with standard diameter implants. The increased bone loss around the 9 mm diameter implants can be explained by the fact that 78.3% of these implants were placed in the maxilla, while 66.7% of the 8 mm implants were placed in the mandible.

In 63.8% of the cases, an additional bone graft was used to fill the residual space of the extraction socket. However, there is no consensus on the indication and the optimal regenerative technique \[[@B62]\]. The success for full bone healing depends on the stabilization of the coagulum, which depends on the distance from the bone to the implant \[[@B63]-[@B66]\]. For this reason, some studies advise the use of a bone graft if the jumping distance is more than 2 mm \[[@B38],[@B39]\].

A full papilla was present at 70.66% of the interproximal sites. Papilla presence was not correlated with bone loss, as confirmed by Degidi et al. \[[@B67]\]. Studies using the same index to evaluate the papilla fill reported a full papilla at 35% to 78% of the sites \[[@B67]-[@B70]\]. The disadvantage of the Papilla Index of Jemt \[[@B41]\] is that scores are based on the fill of the embrasure space and not on a comparison with the pretreatment appearance of the papilla. This makes comparison with other studies and treatment approaches difficult. However, there is evidence that the final form of the papilla is similar for immediate or delayed placement as well as immediate or delayed restoration \[[@B71]\].

CONCLUSIONS
===========

Immediate molar replacement, using a wide body Max^®^ implant, offers good primary stability and limited bone loss over time. However, careful surgery and case selection is recommended to obtain a good result.
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